Kenneth Anderson, M.D., Ph.D.

Dr. Kenneth Anderson is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. After graduating from Johns Hopkins Medical School, he trained in internal medicine at Johns Hopkins Hospital, and then completed hematology, medical oncology, and tumor immunology training at the Dana-Farber Cancer Institute. He is a Doris Duke Distinguished Clinical Research Scientist and American Cancer Society Clinical Research Professor. Over the last four decades, he has developed laboratory and animal models of myeloma in its microenvironment which have allowed for both identification of novel targets and validation of novel targeted and immune therapies. He has then rapidly translated these studies to clinical trials culminating in FDA approval of novel targeted therapies which have markedly improved patient outcome. He has received the American Society of Hematology William Dameshek Prize, the American Association for Cancer Research Joseph H. Burchenal Award, the American Society of Clinical Oncology David A. Karnofsky Award, and the Harvard Medical School Warren Alpert Prize. He has also received the Robert A. Kyle Lifetime Achievement Award from the International Myeloma Foundation and the Waldenstrom Award at the International Myeloma Workshop. He is a Fellow of AACR and ASCO, a member of the National Academy of Medicine as well as Royal College of Physicians and Pathologists, and past President of the International Myeloma Society and American Society of Hematology.